Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity

Maternal cypermethrin exposure during the perinatal period impairs testicular development in C57BL male offspring

Numerous studies have demonstrated that endocrine-disrupting compounds (EDC) are a possible cause of male reproductive organ malfunction and malformation. Cypermethrin (CYP) is a widely used synthetic pyrethroid and a potential EDC. This study aimed to examine the effects of perinatal exposure to low-dose CYP on the development and function of the offspring testes. Pregnant mice were intragastrically administered 0.12 to 12 mg/kg/day CYP from embryonic day 0.5 (E0.5) to weaning (PD21.5, postnatal day 21.5). Maternal exposure to 0.12, 1.2, and 12 mg/kg/day CYP affected the body and organ weight of the offspring. Exposure of CYP led to a dose-dependent decrease in the male-to-female sex ratio. A histopathological analysis revealed a thinner seminiferous epithelium layer at PD21.5, interstitial hyperplasia at PD45.5, and germ cell vacuolization at PD90.5 in the 12 mg/kg/day CYP group. The TUNEL assay results revealed increased germ cell apoptosis in the 12 mg/kg/day CYP group. The serum testosterone (T) level decreased, whereas the estradiol level increased with age in the 1.2 and 12 mg/kg/day CYP groups. The RT-PCR analysis demonstrated decreased expression of T production-related, mitosis-related, and meiosis-related genes in the 1.2 and 12 mg/kg/day CYP groups. The in vitro experimental results demonstrated reduced expression of steroidogenesis genes and decreased T levels. It is concluded that perinatal exposure to low-dose CYP affects testes development and function in adults.

Biodegradation and utilization of organophosphorus pesticide malathion by Cyanobacteria

Three strains of filamentous Cyanobacteria were used to study their growth and utilization of organophosphorus pesticide malathion. A sharp decrease in the growth of the algal strains was observed by increasing the concentration of malathion. Amongst them Nostoc muscorum tolerated different concentrations and was recorded as the highest efficient strain for biodegradation (91%) of this compound. Moreover, carbohydrate and protein content of their cells overtopped the other strains especially at higher concentrations. The algal strains were further subjected to grow under P-limitation in absence and presence of malathion. Although, the algal growth under P-limitation recorded a very poor level, a massive enhanced growth and phosphorous content of cells were obtained when the P-limited medium was amended with malathion. This study clarified that N. muscorum with its capability to utilize malathion as a sole phosphorous source is considered as an inexpensive and efficient biotechnology for remediation of organophosphorus pesticide from contaminated wastewater.

Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies

Developmental immunotoxicity (DIT) is a term given to encompass the environmentally induced disruption of normal immune development resulting in adverse outcomes. A myriad of chemical, physical, and psychological factors can all contribute to DIT. As a core component of the developmental origins of adult disease, DIT is interlinked with three important concepts surrounding health risks across a lifetime: (1) the Barker Hypothesis, which connects prenatal development to later-life diseases, (2) the hygiene hypothesis, which connects newborns and infants to risk of later-life diseases and, (3) fetal programming and epigenetic alterations, which may exert effects both in later life and across future generations. This review of DIT considers: (1) the history and context of DIT research, (2) the fundamental features of DIT, (3) the emerging role of DIT in risk of noncommunicable diseases (NCDs) and (4) the range of risk factors that have been investigated through human research. The emphasis on the human DIT-related literature is significant since most prior reviews of DIT have largely focused on animal research and considerations of specific categories of risk factors (e.g., heavy metals). Risk factors considered in this review include air pollution, aluminum, antibiotics, arsenic, bisphenol A, ethanol, lead (Pb), maternal smoking and environmental tobacco smoke, paracetamol (acetaminophen), pesticides, polychlorinated biphenyls, and polyfluorinated compounds.

Methodologies, bioindicators, and biomarkers for assessing gender-related differences in wildlife exposed to environmental chemicals

Male and female organisms may have significant differences in their exposure, toxicokinetics, and response to chemicals, but gender effects have received relatively little attention, often viewed as a confounder rather than of primary importance. In this paper, we examine some of the key issues and methodologies for incorporating gender in studies of the effects of chemicals on wildlife, and explore bioindicators and biomarkers of gender effects. Examining gender-related differences in response to chemicals is complicated in wildlife because of the vast array of species, and differences in niches, lifespans, reproductive cycles and modes, and population dynamics. Further, organisms are more at risk in some ecosystems than others, which may increase the magnitude of effects. Only by studying wild animals, especially native species, can we truly understand the potential impact of gender-specific effects of chemical exposure on populations. Several factors affect gender-related differences in responses to chemicals, including exposure, age, size, seasonality, and genetic and phenotypic variation. There are clear examples where gender-related differences have had significant effects on reproductive success and population stability, including destabilization of gamete release in invertebrates, and alterations of endocrine and neuroendocrine system functioning in vertebrates. A wide range of new technologies and methods are available for examining gender-related differences in responses to chemicals. We provide examples that show that there are gender-related differences in responses to chemicals that have significant biological effects, and these gender-related differences should be taken into account by scientists, regulators, and policy makers, as well as the public.